Alignment Healthcare, Inc.
ALHCNasdaq
$20.60
↑ +2.8%Jul 17 close · end-of-day
Price
1Y↑ +53.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.4B
Enterprise Value
$4.0B
P/E
206.0
P/S
1.0
P/B
21.2
EV/EBITDA
60.1
PEG
—
FCF Yield
5.1%
Dividend Yield
—
Revenue (TTM)
$4.3B
Net Income (TTM)
$19.8M
Free Cash Flow (TTM)
$226.1M
Gross Margin
—
Operating Margin
0.8%
Net Margin
0.5%
ROE
9.6%
ROIC
—
Debt / Equity
1.6
Net Cash
$402.7M
Return 1Y
+56.6%
Company profile
Management & directors
- Maroney Dawn ChristinePresident
- Kao John EChief Executive Officer
- Hochradel Shane J.Chief Operations Officer
- Konowiecki Joseph SEVP, Corporate Affairs
- Kim HyongChief Medical Officer
- Kent Mark D.President - MSO
- Head James MChief Financial Officer
- Joyce Christopher JChief Legal and Admin. Officer
- Wagner Andreas P.Chief Human Resources Officer
- Burzacchi SebastianCOO - Mgmt Services Org
- Scavo Robert L.Chief Information Officer
- Mansour Adnan R.Chief Digital Officer
Roles derived from SEC Form 4 filings.
Earnings
ALHC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.2B↑ +33.3%
Diluted EPS$0.05↓ -200.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $959.2M | $1.2B | $1.4B | $1.8B | $2.7B | $3.9B |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$5.3M | -$178.1M | -$128.6M | -$127.8M | -$101.6M | $14.8M |
| Net income | -$22.9M | -$195.3M | -$149.5M | -$148.0M | -$128.0M | -$724,000.00 |
| Diluted EPS | -$0.15 | -$1.14 | -$0.83 | -$0.79 | -$0.67 | $0.00 |
| Operating cash flow | $7.6M | -$78.8M | -$45.4M | -$59.2M | $34.8M | $139.9M |
| Free cash flow | — | — | -$69.2M | -$95.2M | -$6.6M | $113.1M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -0.5% | -15.2% | -9.0% | -7.0% | -3.8% | 0.4% |
| Net margin | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $681.3M | $692.4M | $701.2M | $926.9M | $1.0B | $993.7M | $1.0B | $1.2B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$18.4M | -$19.5M | -$22.5M | -$5.4M | $22.7M | $7.7M | -$10.3M | $15.5M |
| Net income | -$24.0M | -$26.4M | -$31.1M | -$9.1M | $15.7M | $3.7M | -$11.0M | $11.4M |
| Diluted EPS | -$0.13 | -$0.14 | -$0.15 | -$0.05 | $0.07 | $0.02 | -$0.04 | $0.05 |
| Operating cash flow | $23.5M | $26.2M | -$8.7M | $16.6M | $29.1M | $144.6M | -$50.4M | $128.7M |
| Free cash flow | $11.8M | $16.9M | -$18.0M | $8.4M | $21.1M | $139.1M | -$55.4M | $121.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -2.7% | -2.8% | -3.2% | -0.6% | 2.2% | 0.8% | -1.0% | 1.3% |
| Net margin | -3.5% | -3.8% | -4.4% | -1.0% | 1.5% | 0.4% | -1.1% | 0.9% |
Company news
Coming soonHeadlines for ALHC will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Maroney Dawn Christine· President | Sale | 177,068 | $20.83 | $3.7M | filing |
| 2026-07-15 | Maroney Dawn Christine· President | Option exercise | 152,068 | $9.06 | $1.4M | filing |
| 2026-07-10 | KAO JOHN E· Chief Executive Officer | Sale | 279,644 | $19.81 | $5.5M | filing |
| 2026-07-10 | KAO JOHN E· Chief Executive Officer | Sale | 18,356 | $20.65 | $378,998.17 | filing |
| 2026-07-01 | KONOWIECKI JOSEPH S· EVP, Corporate Affairs | Sale | 25,000 | $24.00 | $600,000.00 | filing |
| 2026-07-01 | Hochradel Shane J.· Chief Operations Officer | Award | 87,719 | $0.00 | $0.00 | filing |
| 2026-06-26 | KONOWIECKI JOSEPH S· EVP, Corporate Affairs | Sale | 25,000 | $23.00 | $575,000.00 | filing |
| 2026-06-18 | KONOWIECKI JOSEPH S· EVP, Corporate Affairs | Sale | 25,000 | $22.00 | $550,000.00 | filing |
| 2026-06-15 | Maroney Dawn Christine· President | Sale | 30,000 | $19.55 | $586,425.00 | filing |
| 2026-06-12 | Kim Hyong· Chief Medical Officer | Sale | 35,951 | $19.86 | $713,947.31 | filing |
| 2026-06-11 | KONOWIECKI JOSEPH S· EVP, Corporate Affairs | Sale | 25,000 | $21.00 | $525,000.00 | filing |
| 2026-06-10 | KAO JOHN E· Chief Executive Officer | Sale | 223,064 | $20.60 | $4.6M | filing |
| 2026-06-10 | KAO JOHN E· Chief Executive Officer | Sale | 74,936 | $19.65 | $1.5M | filing |
| 2026-06-03 | KONOWIECKI JOSEPH S· EVP, Corporate Affairs | Award | 122,807 | $0.00 | $0.00 | filing |
| 2026-06-03 | Kent Mark D.· President - MSO | Award | 87,719 | $0.00 | $0.00 | filing |
| 2026-06-02 | Kent Mark D.· President - MSO | Buy | 14,848 | $13.31 | $197,626.88 | filing |
| 2026-05-18 | Maroney Dawn Christine· President | Gift | 20,000 | $0.00 | $0.00 | filing |
| 2026-05-15 | Maroney Dawn Christine· President | Sale | 30,000 | $16.09 | $482,565.00 | filing |
| 2026-05-15 | Maroney Dawn Christine· President | Gift | 1,500 | $0.00 | $0.00 | filing |
| 2026-05-11 | KAO JOHN E· Chief Executive Officer | Sale | 280,893 | $16.85 | $4.7M | filing |
| 2026-05-11 | KAO JOHN E· Chief Executive Officer | Sale | 17,107 | $17.54 | $299,971.25 | filing |
| 2026-04-15 | Maroney Dawn Christine· President | Sale | 30,000 | $20.87 | $626,199.00 | filing |
| 2026-04-13 | KAO JOHN E· Chief Executive Officer | Sale | 82,299 | $20.80 | $1.7M | filing |
| 2026-04-10 | KAO JOHN E· Chief Executive Officer | Sale | 201,900 | $20.58 | $4.2M | filing |
| 2026-04-10 | KAO JOHN E· Chief Executive Officer | Sale | 13,801 | $21.38 | $295,044.68 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.